FredRosenMD

Oncology • Chicago, IL

Head & Neck Cancer, Hematologic Oncology

Physician

Join to view full profile

Dr. Rosen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rosen's full profile

Already have an account?

Office
1901 W. Harrison St.
John H. Stroger, Jr. Hospital Of Cook County
Chicago, IL 60612
Phone+1 312-864-7250
Is this information wrong?

Education & Training

University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1988 - 1991
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1983 - 1986
University of Illinois College of MedicineClass of 1983

Certifications & Licensure

IL State Medical License 1983 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer Start of enrollment: 1997 Dec 01
Unknown status
Phase 1, Phase 2
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2009 Nov 01
Active, not recruiting
Phase 3
Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer Start of enrollment: 2010 Aug 11
Completed
Phase 2
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Start of enrollment: 2011 Jun 01
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Biliary Tract Cancer in a Patient with a Virchow’s Node
Yanting Wang, Fred R. Rosen, Rohit Agrawal> ;Clinical Gastroenterology and Hepatology. 2019 Oct 17
40 citations
Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer:...
Harold J. Wanebo, Ju-Whei Lee, Barbara Burtness, John A. Ridge, Musie Ghebremichael, Sharon A. Spencer, D. Psyrri, Eirini Pectasides, David L. Rimm, F. R. Rosen, M. R....> ;Annals of Oncology. 2014 Oct 1
38 citations
EFFICACY AND SAFETY OF TREATING T4 ORAL CAVITY TUMORS WITH PRIMARY CHEMORADIOTHERAPY
Ezra E.W. Cohen, Joshua Baru, Dezheng Huo, Daniel J. Haraf, Maureen Crowley, Mary Ellyn Witt, Elizabeth A. Blair, Ralph R. Weichselbaum, Fred Rosen, Everett E. Vokes, ...> ;Head & Neck. 2009 Aug 1
56 citations
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radi...
Joseph K. Salama, Kerstin M. Stenson, E.O. Kistner, Bharat B. Mittal, Athanassios Argiris, M. E. Witt, Fred R. Rosen, Bruce Brockstein, Ezra E.W. Cohen, Daniel J. Hara...> ;Annals of Oncology. 2008 Oct 1
Family history (FH) and the risk of head and neck cancer (HNCA).
Gupta S, Patel UA, Rosen F> ;J. Clin. Oncol.. 2008-05-20
15 citations
High Survival and Organ Function Rates After Primary Chemoradiotherapy for Intermediate-Stage Squamous Cell Carcinoma of the Head and Neck Treated in a Multicenter Pha...
Ezra E.W. Cohen, Daniel J. Haraf, Marcy A. List, Masha Kocherginsky, Bharat B. Mittal, Fred Rosen, Bruce Brockstein, R. Williams, Mary Ellyn Witt, Kerstin M. Stenson, ...> ;Journal of Clinical Oncology. 2006 Jul 20
Sequential evaluation of reduced radiotherapy doses in a phase II trial of induction chemotherapy (IndCT) followed by concomitant chemoradiotherapy (CTX) for advanced ...
Vokes EE, Stenson KM, Kistner E, Mittal B, Cohen EE, List MA, Brockstein BE, Rosen FR, Witt M, Haraf DJ> ;J. Clin. Oncol.. 2006-06-20
255 citations
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient,...
Bruce Brockstein, Daniel J. Haraf, Alfred Rademaker, Merrill S. Kies, Kerstin M. Stenson, Fred Rosen, Bharat B. Mittal, Harold J. Pelzer, Bing B. Fung, M. E. Witt, Lou...> ;Annals of Oncology. 2004 Aug 1
Treatment of advanced head and neck cancer with induction chemotherapy followed by chemoradiotherapy with reduced radiation dose.
Gustin D, Haraf DJ, Stenson K, Cohen E, Rosen F, Argiris A, Brockstein BE, Witt ME, Dekker A, Vokes EE> ;J. Clin. Oncol.. 2004-07-15
114 citations
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer
Athanassios Argiris, Kerstin M. Stenson, Bruce Brockstein, Bharat B. Mittal, Harold J. Pelzer, Merrill S. Kies, Prathima Jayaram, Louis G. Portugal, Fred Rosen, Daniel...> ;Head & Neck. 2004 May 1
130 citations
Competing Causes of Death and Second Primary Tumors in Patients with Locoregionally Advanced Head and Neck Cancer Treated with Chemoradiotherapy
Athanassios Argiris, Bruce Brockstein, Daniel J. Haraf, Kerstin M. Stenson, Bharat B. Mittal, Merrill S. Kies, Fred Rosen, Borko Jovanovic, Everett E. Vokes> ;Clinical Cancer Research. 2004 Mar 15
7 citations
Severe Dermatologic Reactions at Multiple Sites After Paclitaxel Administration
R. Beri, Fred Rosen, Michael J. Pacini, Swati R Desai> ;The Annals of Pharmacotherapy. 2004 Feb 1
Unresectable, locoregionally advanced head and neck cancer.
Fred Rosen> ;Cancer Treatment and Research. 2004 Jan 1
62 citations
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Daniel J. Haraf, Fred Rosen, Kerstin M. Stenson, Athanassios Argiris, Bharat B. Mittal, Mary Ellyn Witt, Bruce Brockstein, Marcy A. List, Louis G. Portugal, Harold J. ...> ;Clinical Cancer Research. 2003 Dec 1
474 citations
Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Ezra E.W. Cohen, Fred Rosen, Walter M. Stadler, Wendy Recant, Kerstin M. Stenson, Dezheng Huo, Everett E. Vokes> ;Journal of Clinical Oncology. 2003 May 15
69 citations
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin ...
Fred Rosen, Daniel J. Haraf, Merrill S. Kies, Kerstin M. Stenson, Louis G. Portugal, Marcy A. List, Bruce Brockstein, Bharat B. Mittal, Alfred Rademaker, Mary Ellyn Wi...> ;Clinical Cancer Research. 2003 May 1
203 citations
Weekly Carboplatin and Paclitaxel Followed by Concomitant Paclitaxel, Fluorouracil, and Hydroxyurea Chemoradiotherapy: Curative and Organ-Preserving Therapy for Advanc...
Everett E. Vokes, Kerstin M. Stenson, Fred Rosen, Merrill S. Kies, Alfred W. Rademaker, Mary Ellyn Witt, Bruce Brockstein, Marcy A. List, Bing Bing Fung, Louis G. Port...> ;Journal of Clinical Oncology. 2003 Jan 15
1 citations
Curative treatment for advanced head and neck cancer in the community: has the time come?
Fred Rosen, Everett E. Vokes> ;Cancer Journal. 2002 Jul 1
131 citations
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
Merrill S. Kies, Daniel J. Haraf, Fred Rosen, Kerstin M. Stenson, Marcy A. List, Bruce Brockstein, Theodore D.K. Chung, Bharat B. Mittal, Harold J. Pelzer, Louis G. Po...> ;Journal of Clinical Oncology. 2001 Apr 1
12 citations
Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer.
Thomas E. Lad, Fred Rosen, D. Sciortino, Bruce Brockstein, Keubler Jp, R. Arietta, Everett E. Vokes> ;Investigational New Drugs. 2000 Aug 1
12 citations
Endoscopic Surgical Management of Sphenoid Sinus Disease
Fred Rosen, Uttam K. Sinha, Dale H. Rice> ;The Laryngoscope. 1999 Oct 1
4 citations
Radiotherapy alone compared with radiotherapy and chemotherapy in patients with squamous cell carcinoma of the esophagus.
Sarada P. Reddy, Thomas E. Lad, Michael Russell Mullane, Fred Rosen, Rosemary Carroll, James E. Marks> ;American Journal of Clinical Oncology. 1995 Oct 1
3 citations
Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck : An Illinois Cancer Center Study
Fred Rosen, Everett E. Vokes, Thomas E. Lad, Merrill S. Kies, James L. Wade, Lary J. Kilton, Richard R. Blough, Suzanne French, Michael Russell Mullane, Al B. Benson> ;Investigational New Drugs. 1995 Sep 1
5 citations
A point mutation in exon 2 of the CD40 ligand gene causes the simultaneous expression of two defective mRNA species in X-linked hyperimmunoglobulinemia M
Narayanaswamy Ramesh, Ramsay Fuleihan, Paul Swinton, Fred Rosen, Raif S. Geha> ;Human Molecular Genetics. 1995 Apr 1
16 citations
Use of nude mouse xenografts as preclinical drug screens. Further studies on in vitro growth of xenograft tumor colony-forming cells.
Raymond Taetle, Honeysett Jm, Rosen F, Shoemaker R> ;Cancer. 1986 Nov 1
Join now to see all

Press Mentions

The 2023 ACR Awards of DistinctionNovember 16th, 2023

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

John H. Stroger Jr. Hospital of Cook CountyChicago, Illinois
University of Illinois HospitalChicago, Illinois